Allspring Global Investments Holdings LLC bought a new position in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 9,691 shares of the insurance provider's stock, valued at approximately $509,000. Allspring Global Investments Holdings LLC owned approximately 0.05% of AMERISAFE at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in the company. Royce & Associates LP purchased a new position in AMERISAFE during the fourth quarter valued at approximately $15,738,000. Raymond James Financial Inc. acquired a new stake in AMERISAFE in the fourth quarter valued at approximately $9,708,000. Geode Capital Management LLC lifted its stake in AMERISAFE by 18.4% in the fourth quarter. Geode Capital Management LLC now owns 536,836 shares of the insurance provider's stock valued at $27,675,000 after acquiring an additional 83,297 shares during the last quarter. GAMMA Investing LLC lifted its stake in AMERISAFE by 6,160.6% in the first quarter. GAMMA Investing LLC now owns 84,080 shares of the insurance provider's stock valued at $4,418,000 after acquiring an additional 82,737 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in AMERISAFE by 92.1% in the fourth quarter. Nuveen Asset Management LLC now owns 161,815 shares of the insurance provider's stock valued at $8,340,000 after acquiring an additional 77,582 shares during the last quarter. 97.41% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, JMP Securities reiterated a "market outperform" rating and issued a $65.00 target price on shares of AMERISAFE in a research note on Wednesday, April 30th.
Read Our Latest Report on AMSF
AMERISAFE Stock Performance
Shares of AMERISAFE stock traded up $0.66 on Monday, reaching $44.82. The stock had a trading volume of 103,925 shares, compared to its average volume of 108,498. The stock has a market cap of $853.82 million, a P/E ratio of 18.07 and a beta of 0.40. The business's 50-day moving average price is $45.42 and its two-hundred day moving average price is $48.56. AMERISAFE, Inc. has a fifty-two week low of $42.48 and a fifty-two week high of $60.24.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The insurance provider reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.59 by $0.01. AMERISAFE had a net margin of 15.76% and a return on equity of 16.41%. The firm had revenue of $83.78 million for the quarter, compared to analyst estimates of $76.66 million. As a group, equities analysts forecast that AMERISAFE, Inc. will post 2.45 earnings per share for the current fiscal year.
AMERISAFE Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 13th were given a dividend of $0.39 per share. The ex-dividend date of this dividend was Friday, June 13th. This represents a $1.56 annualized dividend and a yield of 3.48%. AMERISAFE's dividend payout ratio (DPR) is 62.90%.
About AMERISAFE
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Further Reading

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.